Twin-track studies of ifosfamide and mitoxantrone (I-M) in recurrent high grade non-hodgkin's lymphoma and hodgkin's disease-Reference-Cited by-同舟云学术

Twin-track studies of ifosfamide and mitoxantrone (I-M) in recurrent high grade non-hodgkin's lymphoma and hodgkin's disease

Published:2006-07 Issue:4-5 Volume:9 Page:235-244
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol. Oncol.

Author:

Child J. A.,Simmons A. V.,Barnard D. L.,Parapia L.,Morgan M.,Grace R. J.,Fletcher J.,Parker D.,Norfolk D. R.,Stone J.,Stuart N. S. A.,Tucker J.,Dovey G. J.

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference27 articles.

1. IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy

2. Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic type

3. Results of MIME salvage regimen for recurrent or refractory lymphoma.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-dose ifosfamide and mitoxantrone (HDIM) in patients with relapsed or refractory Hodgkin’s lymphoma;Annals of Hematology;2016-04-22

2. Management of Lymphoma Patients in a Cancer Unit: An Audit of 15 Years' Experience in a District General Hospital;Clinical Oncology;2001-08

3. High Dose Ifosfamide in Combination with Etoposide and Epirubicin Followed by Autologous Stem Cell Transplantation in the Treatment of Relapsecd/Refractory Hodgkin's Disease: a Report on Toxicity and Efficacy On behalf of the Scotland and Newcastle Lymphoma Group;Leukemia & Lymphoma;2000-01

4. FLUDAP: Salvage Chemotherapy for Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma;Leukemia & Lymphoma;2000-01

5. Pilot Study and Randomised Trial of Mitozantrone and Ifosfamide for Relamed Non-Hodgkin’ s Lymphoma;Leukemia & Lymphoma;1993-01